2022 CDC Clinical Practice Guideline for Prescribing Opioids Implementation Guide
2022.1.0 - Release 2022.1

2022 CDC Clinical Practice Guideline for Prescribing Opioids Implementation Guide, published by CDC / Security Risk Solutions, Inc. (SRS). This guide is not an authorized publication; it is the continuous build for version 2022.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/security-rs/opioid-cds-r4/ and changes regularly. See the Directory of published versions

Parameters: Input Expansion Parameters

Parameters

system-versionhttp://snomed.info/sct|http://snomed.info/sct/731000124108/version/20250901
default-canonical-versionhttp://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-computablevalueset|1.0.0
default-canonical-versionhttp://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-executablevalueset|1.0.0
system-versionhttp://hl7.org/fhir/sid/icd-10-cm|2.0.1
default-canonical-versionhttp://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-shareablelibrary|1.0.0
default-canonical-versionhttp://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-computablelibrary|1.0.0
default-canonical-versionhttp://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-publishablelibrary|1.0.0
default-canonical-versionhttp://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-executablelibrary|1.0.0
system-versionhttp://terminology.hl7.org/CodeSystem/usage-context-type|2.0.1
system-versionhttp://fhir.org/guides/cdc/opioid-mme-r4/CodeSystem/CDCMMEUsageContextCodes|3.0.0
default-canonical-versionPatient
system-versionhttp://www.nlm.nih.gov/research/umls/rxnorm|3.0.1
system-versionhttp://loinc.org|3.1.0
default-valueset-versionLimited life expectancy conditions
default-valueset-versionTherapies indicating end of life care
default-valueset-versionConditions likely terminal for opioid prescribing
default-valueset-versionCDC malignant cancer conditions
default-valueset-versionOncology specialty designations (NUCC)
default-valueset-versionOpioid misuse disorders
default-valueset-versionSubstance misuse behavioral counseling
default-valueset-versionConditions documenting substance misuse
default-valueset-versionOffice Visit
default-valueset-versionOpioid counseling procedure
default-valueset-versionOpioid misuse assessment procedure
default-valueset-versionHospice Disposition
default-valueset-versionHospice Finding
default-valueset-versionObservation Category Laboratory
default-valueset-versionObservation Category Procedure
default-valueset-versionPain treatment plan
default-valueset-versionPain management procedure
default-valueset-versionPDMP review procedure
default-valueset-versionPDMP data reviewed finding
default-valueset-versionSleep disordered breathing
default-valueset-versionOpioid analgesics with ambulatory misuse potential
default-valueset-versionExtended release opioid with ambulatory misuse potential
default-valueset-versionBuprenorphine Medications
default-valueset-versionBuprenorphine and Methadone medications
default-valueset-versionNon-synthetic opioid medications
default-valueset-versionBarbiturate Medications
default-valueset-versionBenzodiazepine medications
default-valueset-versionNaloxone medications
default-valueset-versionFentanyl-type medications
default-valueset-versionAmphetamine class medications
default-valueset-versionMethadone medications
default-valueset-versionOxycodone Medications
default-valueset-versionSynthetic opioid medications
default-valueset-versionCNS depressant medications
default-valueset-versionAll urine drug screening tests
default-valueset-versionNon-opioid drug urine screening
default-valueset-versionOpiate specific urine drug screening tests
default-valueset-versionGeneral opiate urine drug screening tests
default-valueset-versionOpioid drug urine screening
default-valueset-versionCocaine urine drug screening tests
default-valueset-versionPhencyclidine urine drug screening tests
default-valueset-versionFentanyl-type urine drug screening tests
default-valueset-versionAmphetamine-class drugs and metabolite urine tests
default-valueset-versionCannabinoid class urine drug screening
default-valueset-versionMethadone urine drug screening tests
default-valueset-versionSynthetic opioid urine drug screening tests
default-valueset-versionBarbiturate urine drug screening tests
default-valueset-versionBenzodiazepine urine drug screening tests
default-valueset-versionBuprenorphine urine drug screening tests
default-valueset-versionHeroin urine drug screening tests
default-valueset-versionOxycodone urine drug screening tests
default-valueset-versionValueSet - Medication Request Category Community
default-valueset-versionCondition Clinical Status Active
default-valueset-versionValueSet - Medication Request Status Active
default-valueset-versionEncounter Diagnosis Condition Category
default-valueset-versionProblem List Condition Category
default-valueset-versionUS Core Health Concern Condition Category
default-valueset-versionSickle-cell diseases
default-canonical-versionMedicationRequest
default-canonical-versionMedication
default-canonical-versionCondition
default-canonical-versionObservation
default-canonical-versionEncounter
default-canonical-versionCarePlan
default-canonical-versionProcedure
default-canonical-versionMedicationDispense
default-canonical-versionhttp://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-recommendationdefinition|1.0.0
default-canonical-versionhttp://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-publishableplandefinition|1.0.0
default-canonical-versionLibrary - Recommendation #1 - Nonpharmacologic and Nonopioid Pharmacologic Therapy Consideration
default-canonical-versionLibrary - Recommendation #2 - Opioid Therapy Goals Discussion
default-canonical-versionLibrary - Recommendation #3 - Opioid Immediate Release Form When Starting Opioid Therapy
default-canonical-versionLibrary - Recommendations #4 and #5 - Lowest Effective Dose
default-canonical-versionLibrary - Recommendation #6 - Prescribe Lowest Effective Dose and Duration
default-canonical-versionLibrary - Recommendation #7 - Opioid Therapy Risk Assessment
default-canonical-versionhttp://fhir.org/guides/cdc/opioid-cds/ActivityDefinition/opioidcds-risk-assessment-request|2022.1.0
default-canonical-versionLibrary - Recommendation #8 - Naloxone Consideration
default-canonical-versionLibrary - Recommendation #9 - Consider Patient's History of Controlled Substance Prescriptions
default-canonical-versionLibrary - Recommendation #10 - Urine Drug Testing
default-canonical-versionLibrary - Recommendation #10 Patient View - Urine Drug Testing
default-canonical-versionhttp://fhir.org/guides/cdc/opioid-cds/ActivityDefinition/opioidcds-urine-screening-request|2022.1.0
default-canonical-versionLibrary - Recommendation #11 - Concurrent Use of Opioids and Benzodiazepines
default-canonical-versionLibrary - Recommendation #11 Patient View - Concurrent Use of Opioids and Benzodiazepines
default-canonical-versionLibrary - Recommendation #12 (patient-view) - Evidence-based Treatment for Patients with Opioid Use Disorder
default-canonical-versionExtension
default-canonical-versionElement
default-canonical-versionValueSet
default-canonical-versionDomainResource
default-valueset-versionAll Languages
default-canonical-versionCDC 2022 Opioid Guidance Clinical Focus Extension
default-canonical-versionCDC 2022 Opioid Guidance Data Element Extension
default-canonical-versionCDC 2022 Opioid Guidance Inclusion Criteria Extension
default-canonical-versionCDC 2022 Opioid Guidance exclusion Criteria Extension